OptimizeRx names former J&J data science officer as company advisor

OptimizeRx Corp. (Nasdaq: OPRX) has appointed Troy Sarich, a former Johnson & Johnson executive, as a company advisor, according to a press release from the Waltham, Massachusetts-based healthcare technology firm.

Sarich previously served as Chief Commercial Data Science Officer at Johnson & Johnson, where he worked on scientific and commercial capabilities for the company's Innovative Medicine business. He brings nearly 30 years of experience in global healthcare, life sciences, and pharmaceutical commercialization, with a focus on data, analytics, and artificial intelligence.

During his career, Sarich held positions in research and development and commercial organizations, with involvement in clinical development and commercialization of medicines across cardiology, oncology, immunology, and neuroscience.

In his advisory role, Sarich is expected to inform the development of OptimizeRx's technology and data offerings. "OptimizeRx has led the way in its industry, equipping life sciences marketers with solutions that harness data to improve commercial decision-making and audience engagement," Sarich said. "I look forward to helping guide this momentum and ensuring we continue to keep pace with the evolving needs of brands, patients, and providers."

Stephen Silvestro, Chief Executive Officer of OptimizeRx, said Sarich's knowledge of data, AI, and digital technologies aligns with the company's mission to deliver therapies to patients.

You May Also Be Interested In

• HII targets 15% shipbuilding throughput increase for U.S. Navy in 2026
• Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
• JPMorgan Reiterates Overweight Rating on Fortis Healthcare Ltd (FORH:IN)